In the atorvastatin group of MIRACL , short-term risk increased across tertiles of baseline triglycerides ( p = 0.03 ) , with a hazard ratio of 1.50 [ corrected ] ( 95 % confidence interval : 1.05 to 2.15 ) in highest/lowest tertiles ( > 195/135 mg/dl ) .